Pharmacists' considerations on non-medical switching at the hospital: a systematic review of the economic outcomes of cost-saving therapeutic drug classes.
Marko KrsticJean-Christophe Alain DevaudFarshid SadeghipourPublished in: European journal of hospital pharmacy : science and practice (2021)
Regardless of the exclusion of studies regarding biologics or medicines used in oncology, the review highlights that NMS strategies with medicines whose management do not require a thorough clinical assessment were associated with reduced costs and no significant changes in patients' health outcomes, in the inpatient setting. NMS strategies targeting medicines that require an extensive clinical assessment should be evaluated using hospital-specific effectiveness and/or utility data prior to their implementation.
Keyphrases
- healthcare
- end stage renal disease
- palliative care
- acute care
- ejection fraction
- randomized controlled trial
- newly diagnosed
- adverse drug
- chronic kidney disease
- primary care
- systematic review
- prognostic factors
- mental health
- emergency department
- big data
- drug delivery
- weight loss
- patient reported outcomes
- adipose tissue
- skeletal muscle